TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
XGN

Exagen Inc

Healthcare · Diagnostics & Research

8.70$ +1.4% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Exagen Inc (XGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 52 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XGN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
61 57 51 49 44 45 40 59 63 58 52 52
49 48 42 41 36 36 33 51 53 49 44 43
28 36 27 24 22 22 11 30 36 32 22 25
28 36 27 24 22 22 11 30 36 32 22 25
17 6.6 11 12 9.4 7.8 15 15 11 11 16 12
2.2 2.9 2.1 2.9 2.9 3.5
33 34 31 32 31 35 34 38 45 41 38 40
10 12 8.8 9.4 8.8 14 14 10 13 14 13 13
1.9 1.2 1.7 1.8 1.8 1.7 3.7 1.8 3.0 3.0 3.0 1.6
1.7 3.1 1.5 2.3 1.1 4.1 4.5 2.5 3.6 4.2 4.2 4.4
19 19 19 20 20 20 18 22 22 22 22 22
28 23 20 18 13 9.5 6.4 21 18 17 14 12
-274 -279 -283 -286 -291 -294 -298 -303 -310 -314 -318 -321
18 18 18 18 18 18 19 21 23 22 24 24

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?